BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6266961)

  • 1. Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.
    Oakes JE; Lausch RN
    Infect Immun; 1981 Jul; 33(1):109-14. PubMed ID: 6266961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fc-dependent functions but not C' cytolysis and C5 chemotaxis.
    McKendall RR
    J Infect Dis; 1985 Mar; 151(3):464-70. PubMed ID: 2982965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: requirement of Fc portion of antibody.
    Hayashida I; Nagafuchi S; Hayashi Y; Kino Y; Mori R; Oda H; Ohtomo N; Tashiro A
    Microbiol Immunol; 1982; 26(6):497-509. PubMed ID: 6290850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between herpes simplex type 1-induced Fc receptor and human and rabbit immunoglobulin G (IgG) domains.
    Johansson PJ; Schröder AK; Nardella FA; Mannik M; Christensen P
    Immunology; 1986 Jun; 58(2):251-5. PubMed ID: 3011655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antiglobulin-mediated neutralization of herpes simplex virus-IgG complexes by complement and heterologous anti-immunoglobulin.
    Shivers JC; Daniels CA
    Arch Virol; 1979; 59(1-2):89-97. PubMed ID: 218539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
    Melewicz FM; Shore SL; Ades EW; Phillips DJ
    J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease.
    Collins JJ; Sackie DM; Johnson GR
    Virology; 1983 Apr; 126(1):259-66. PubMed ID: 6573816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.
    Frank I; Friedman HM
    J Virol; 1989 Nov; 63(11):4479-88. PubMed ID: 2552134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection by indirect immunofluorescence of Fc receptors in cells acutely infected with Herpes simplex virus.
    Feorino PM; Shore SL; Reimer CB
    Int Arch Allergy Appl Immunol; 1977; 53(3):222-33. PubMed ID: 192682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro neutralization of HSV-2: inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR).
    Dowler KW; Veltri RW
    J Med Virol; 1984; 13(3):251-9. PubMed ID: 6327900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.
    Dai HS; Griffin N; Bolyard C; Mao HC; Zhang J; Cripe TP; Suenaga T; Arase H; Nakano I; Chiocca EA; Kaur B; Yu J; Caligiuri MA
    Immunity; 2017 Jul; 47(1):159-170.e10. PubMed ID: 28723548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.
    Rector JT; Lausch RN; Oakes JE
    Infect Immun; 1982 Oct; 38(1):168-74. PubMed ID: 6292092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rheumatoid factor and anti-immunoglobulin G antibodies on complement-mediated lysis of herpes simplex virus-infected human fibroblasts.
    Shivers JC; Daniels CA
    Infect Immun; 1977 Feb; 15(2):478-84. PubMed ID: 191401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies.
    Mathews JH; Roehrig JT; Trent DW
    J Virol; 1985 Sep; 55(3):594-600. PubMed ID: 2410632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composition of immune deposits present in glomeruli of NZB/W F1 mice.
    Sugisaki T; Takase S
    Clin Immunol Immunopathol; 1991 Dec; 61(3):296-308. PubMed ID: 1934620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Schlesinger JJ; Foltzer M; Chapman S
    Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing activities of early and late IgG fragments from rabbits immunized with herpes simplex virus.
    Shinkai K; Yoshino K
    Jpn J Microbiol; 1975 Jun; 19(3):211-8. PubMed ID: 170444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological mechanisms giving rise to latency of herpes simplex virus in the spinal ganglia of the mouse.
    Schneweis KE; Brado M; Ebers B; Friedrich A; Olbrich M; Schüler W
    Med Microbiol Immunol; 1988; 177(1):1-8. PubMed ID: 2828899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties.
    McTaggart SP; Burns WH; White DO; Jackson DC
    J Immunol; 1978 Aug; 121(2):726-30. PubMed ID: 681755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.